Keros Therapeutics, Inc. (KROS) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Keros Therapeutics, Inc. (KROS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $446.3M, listed on NASDAQ, employing roughly 163 people, carrying a beta of 0.95 to the broader market. Keros Therapeutics, Inc. Led by Jasbir S. Seehra, public since 2020-04-08.
Snapshot as of May 14, 2026.
- Spot Price
- $11.04
- Total OI
- 4.4K